Aneuvo CEO Yi-Kai Lo Presents at Unite 2 Fight for Paralysis

Aneuvo CEO Yi-Kai Lo to Present at Unite 2 Fight for Paralysis

The symposium is “a collaborative gathering that prioritizes the voice of the Spinal Cord Injury (SCI) Community, bringing together research scientists, clinicians, and community advocates, along with investors and industry leaders to exchange information and strategies for achieving recovery from SCI.” The event takes place Thursday, October 21, through Saturday, October 23, 2021.

Read More

Aneuvo Awarded $999,999 from the National Science Foundation

Aneuvo Awarded $999,999 from the National Science Foundation

Aneuvo* today announced that it has been recently awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $999,999 to conduct research and development work on an ingestible bioelectronic capsule for closed-loop diagnosis and treatment of gastrointestinal (GI) disorders. With this grant, Aneuvo will advance its novel GI technology development toward pre-clinical validation.

Read More

Niche Biomedical is rebranding as Aneuvo

We are now Aneuvo.

Niche Biomedical is rebranding in preparation for continued growth and success! The name reflects new approaches to treatment, neural technology, and neural therapies and sets us apart as we begin moving toward future clinical trials and, ultimately, commercialization. We appreciate your support, encouragement, and attention since the formation of Niche Biomedical in 2016. We look forward to bringing innovative and effective medical solutions to help patients in need.

Go to Top